Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22964-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- BARD1 antibody
- Antibody type
- Polyclonal
- Description
- BARD1 antibody (Cat. #22964-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references CBX2 phase-separation contributes to homologous recombination repair and drug resistance in ovarian cancer.
CHB-Induced Immune Zonation Chaos Elicited LXRα-mediated Lipid Metabolism Disorders in Kupffer Cells to Induce Cancer Stem Cell Formation.
Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K/AKT signaling pathway.
The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.
FOXO3a Mediates Homologous Recombination Repair (HRR) via Transcriptional Activation of MRE11, BRCA1, BRIP1, and RAD50.
53BP1 and BRCA1 control pathway choice for stalled replication restart.
Sun S, Huang L, Ma Y, Wei Z, Zhu M, Chen M, Ying F, Zhou X, Yang P, Wen Y, Yang Q, Cai L, Zhang Y, Cai J
Cell death & disease 2026 Mar 26;17(1)
Cell death & disease 2026 Mar 26;17(1)
CHB-Induced Immune Zonation Chaos Elicited LXRα-mediated Lipid Metabolism Disorders in Kupffer Cells to Induce Cancer Stem Cell Formation.
Shi J, Li Q, Li J, Bai J, Xi J, He Q, Zhou J, Wang X, Song X, Li X, Yue X, Zhang X, Sun Z, Li J, Yang W, Cui Y, Shu W, Guo L, Wang S
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(10):e10275
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Feb;13(10):e10275
Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K/AKT signaling pathway.
Yang C, Zhang Y, Liu Y, Wu X, Sun F
Discover oncology 2025 May 21;16(1):840
Discover oncology 2025 May 21;16(1):840
The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination.
Wang L, Wu X, Paul A, Yao J, Wang B
PLoS biology 2025 Dec;23(12):e3003545
PLoS biology 2025 Dec;23(12):e3003545
Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis.
Chen Y, Zhou Y, Feng X, Wu Z, Yang Y, Rao X, Zhou R, Meng R, Dong X, Xu S, Zhang S, Wu G, Jie X
Cell death & disease 2024 Jan 31;15(1):104
Cell death & disease 2024 Jan 31;15(1):104
FOXO3a Mediates Homologous Recombination Repair (HRR) via Transcriptional Activation of MRE11, BRCA1, BRIP1, and RAD50.
Inci G, Warkad MS, Kang BG, Lee NK, Suh HW, Lim SS, Kim J, Kim SC, Lee JY
Molecules (Basel, Switzerland) 2022 Dec 6;27(23)
Molecules (Basel, Switzerland) 2022 Dec 6;27(23)
53BP1 and BRCA1 control pathway choice for stalled replication restart.
Xu Y, Ning S, Wei Z, Xu R, Xu X, Xing M, Guo R, Xu D
eLife 2017 Nov 6;6
eLife 2017 Nov 6;6
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- SH-SY5Y cells were subjected to SDS PAGE followed by western blot with 22964-1-AP( BARD1 Antibody) at dilution of 1:300
- Other comments
- WB
